RE:ONCY Presented Positive GOBLET Pancreatic Cancer Data @ ESMODecember 11, 2024 - Dr. Nadine van Montfoort and colleagues at Leiden University Medical Center have made significant strides in understanding the potential of 'Reo' (Reovirus type 3 Dearing/pelareorep) in cancer treatment.
In a recent study, coordinated by Dr. Christianne Groeneveldt, van Montfoort’s team confirmed that the immune-stimulating properties of 'Reo' can be harnessed to work by infecting and killing cancer cells directly and by stimulating the body’s immune system to attack the tumor, regardless of the presence of neutralizing antibodies.
They found that Reo is especially promising because it can prime a tumor microenvironment to become more amenable to immunotherapy.